Prime Medicine, Inc. (PRME)
CIK 1894562 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Prime Medicine, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 6, 2026 | 8-K | 0001628280-26-053878 |
| Aug 6, 2026 | 10-Q | 0001628280-26-053883 |
| Jul 8, 2026 | 8-K | 0001628280-26-047590 |
| Jun 8, 2026 | 4 | 0001628280-26-041553 |
| Jun 8, 2026 | 4 | 0001628280-26-041575 |
| Jun 8, 2026 | 4 | 0001628280-26-041579 |
| Jun 8, 2026 | 4 | 0001628280-26-041569 |
| Jun 8, 2026 | 8-K | 0001628280-26-041543 |
| Jun 8, 2026 | 4 | 0001628280-26-041566 |
| Jun 8, 2026 | 4 | 0001628280-26-041560 |
| Jun 8, 2026 | 4 | 0001628280-26-041572 |
| May 7, 2026 | 8-K | 0001628280-26-031719 |
| May 7, 2026 | 10-Q | 0001628280-26-031726 |
| Apr 23, 2026 | DEF 14A | 0001628280-26-026697 |
| Apr 23, 2026 | DEFA14A | 0001628280-26-026701 |
| Apr 23, 2026 | ARS | 0001628280-26-026704 |
| Apr 17, 2026 | 3 | 0001470831-26-000386 |
| Apr 17, 2026 | 4 | 0001470831-26-000388 |
| Apr 16, 2026 | 8-K | 0001628280-26-025372 |
| Mar 4, 2026 | EFFECT | 9999999995-26-000723 |
| Mar 3, 2026 | 8-K | 0001628280-26-013565 |
| Mar 3, 2026 | POSASR | 0001894562-26-000007 |
| Mar 3, 2026 | S-8 | 0001628280-26-013575 |
| Mar 3, 2026 | 10-K | 0001628280-26-013569 |
| Mar 3, 2026 | POS AM | 0001894562-26-000009 |